Remote Field-Based Key Account Manager – Rare Diseases

Chiesi USA, Inc.; Kentucky; On-site; USD 175,000 - 195,000; Full time

Benefits offered by this job

Remote work options

Relocation assistance

Healthcare programs

Performance bonuses

Job summary

Chiesi USA, Inc. is seeking a Field-Based Key Account Manager (KAM) to drive rare disease product adoption across multiple states, focusing on prescribers and their staff.

The role emphasizes strategic account management, effective data analysis, and compliant engagement with healthcare professionals. The KAM will deliver disease education, payer access information, and resources to support prescribing, initiation, and ongoing therapy.

Qualifications

• Bachelor’s degree; science or business preferred.
• 10+ years pharma industry experience.
• Clinical experience selling rare diseases.
• Strong local relationships and market knowledge.
• Proven top sales performance.
• Excellent virtual/remote selling and customer engagement skills.

Responsibilities

• Create awareness around rare disease states based on marketed products.
• Business development and prospecting.
• Strategic account management—translate strategy into action.
• Target, plan, and work across states/regions.
• Manage leads with timely follow-up.
• Meet and exceed sales forecasts and objectives.
• Collaborate with marketing, sales leadership, and other partners on local market needs.
• Execute marketing initiatives and support HCP conferences.
• Adhere to compliance guidelines and complete trainings.

Skills

Account management

Remote selling

Customer engagement

Strategic planning

Communication skills

Education

Bachelor's degree in science or business

Tools

Veeva

Salesforce.com

Microsoft Office

Concur

Zoom

Microsoft Teams

WebEx

Job description

Chiesi USA, Inc. is seeking a Field-Based Key Account Manager (KAM) to drive rare disease product adoption across multiple states, focusing on prescribers and their staff.

The role emphasizes strategic account management, effective data analysis, and compliant engagement with healthcare professionals. The KAM will deliver disease education, payer access information, and resources to support prescribing, initiation, and ongoing therapy.